Lysosome-associated protein 1 (LAMP-1) and Lysosome-associated protein 2 (LAMP-2) in a larger family carrier of Fabry disease

Gene

Volumn 536, Issue 1, 2014, Pages 118-122

  Pereira, Ester M ^a   do Monte, Semiramis J H ^a   do Nascimento, Fernando F ^a   de Castro, Jose A F ^a   Sousa, Jackeline L M ^a   Filho, Henrique C S A L C ^a   da Silva, Raimundo N ^a   Labilloy, Anatália ^a   Monte Neto, José T ^a   da Silva, Adalberto S ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Enzyme replacement therapy; Fabry disease; LAMP 1; LAMP 2

Indexed keywords

AGALSIDASE ALFA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME REPLACEMENT; FABRY DISEASE; FAMILIAL DISEASE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HETEROZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NORMAL HUMAN; PHAGOCYTE; PRIORITY JOURNAL; TREATMENT RESPONSE; YOUNG ADULT;

EID: 84891828223     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.063     Document Type: Article

References (24)

1. Aerts J.M., Groener J.E., et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(8):2812-2817.
2. Anderson W. A case of "angeiokeratoma". Br. J. Dermatol. 1898, 10:113-117.
3. Bishop D.F., Kornreich R., et al. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc. Natl. Acad. Sci. U. S. A. 1988, 85(11):3903-3907.
4. Cuervo A.M., Dice J.F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996, 273(5274):501-503.
5. De Duve C. The lysosome. Sci. Am. 1963, 208:64-72.
6. Eskelinen E.L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med. 2006, 27(5-6):495-502.
7. Eskelinen E.L., Tanaka Y., et al. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003, 13(3):137-145.
8. Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae). Cardiac manifestations of Anderson-Fabry disease in children and adolescents. Arch. Dermatol. Syph. 1898, 43:187-200.
9. Huynh K.K., Eskelinen E.L., et al. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007, 26(2):313-324.
10. Isaac E.L., Karageorgos L.E., et al. Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage. Exp. Cell Res. 2000, 254(2):204-209.
11. Karageorgos L.E., Isaac E.L., et al. Lysosomal biogenesis in lysosomal storage disorders. Exp. Cell Res. 1997, 234(1):85-97.
12. Kornfeld S., Mellman I. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 1989, 5:483-525.
13. Nishino I., Fu J., et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000, 406(6798):906-910.
14. Opitz J.M., Stiles F.C., et al. The genetics of angiokeratoma corporis diffusum (Fabry's Disease) and its linkage relations with the Xg locus. Am. J. Hum. Genet. 1965, 17(4):325-342.
15. Saftig P., Beertsen W., et al. LAMP-2: a control step for phagosome and autophagosome maturation. Autophagy 2008, 4(4):510-512.
16. Schmidt H., Gelhaus C., et al. Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells. Cell Commun. Signal. 2011, 9(1):4.
17. Schneede A., Schmidt C.K., et al. Role for LAMP-2 in endosomal cholesterol transport. J. Cell. Mol. Med. 2009, 15(2):280-295.
18. Shabbeer J., Yasuda M., et al. Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations. Hum. Genomics 2006, 2(5):297-309.
19. Sun Y., Grabowski G.A. Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease. Autophagy 2010, 6(5):658-659.
20. Winchester B. The lysosome: structure, organization and function. Fundam. Med. Cell Biol. 1992, 4:305-361.
21. Winchester B.G. Lysosomal membrane proteins. Eur. J. Paediatr. Neurol. 2001, 5:11-19. (Suppl. A).
22. Wu G., Huang J., et al. LAMP-2 gene expression in peripheral leukocytes is increased in patients with coronary artery disease. Clin. Cardiol. 2011, 34(4):239-243.
23. Young E., Mills K., et al. Is globotriaosylceramide a useful biomarker in Fabry disease?. Acta Paediatr. Suppl. 2005, 94(447):51-54. (discussion 37-58).
24. Zhou D., Li P., et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005, 22(5):571-581.